4.8 Article

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): Discovery of EPPTB (RO5212773)

Henri Stalder et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Pharmacology & Pharmacy

RG3487, a Novel Nicotinic alpha 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents

Tanya L. Wallace et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)

Article Pharmacology & Pharmacy

Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor

Stefano Espinoza et al.

MOLECULAR PHARMACOLOGY (2011)

Article Multidisciplinary Sciences

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Florent G. Revel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Multidisciplinary Sciences

Rethinking schizophrenia

Thomas R. Insel

NATURE (2010)

Article Behavioral Sciences

Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential

Daniela Alberati et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)

Review Pharmacology & Pharmacy

Preclinical models of antipsychotic drug-induced metabolic side effects

Heidi N. Boyda et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2010)

Review Pharmacology & Pharmacy

Trace Amine-Associated Receptors as Emerging Therapeutic Targets

Tatyana D. Sotnikova et al.

MOLECULAR PHARMACOLOGY (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Validation of Cerebral Blood Perfusion Imaging as a Modality for Quantitative Pharmacological MRI in Rats

Andreas Bruns et al.

MAGNETIC RESONANCE IN MEDICINE (2009)

Article Multidisciplinary Sciences

The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system

Amyaouch Bradaia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Neurosciences

RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors

Theresa M. Ballard et al.

PSYCHOPHARMACOLOGY (2009)

Review Behavioral Sciences

Modulation of stress by imidazoline binding sites: Implications for psychiatric disorders

Karen L. Smith et al.

STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2009)

Article Biochemistry & Molecular Biology

Anatomical Profiling of G Protein-Coupled Receptor Expression

Jean B. Regard et al.

Review Neurosciences

Enhancing Aromatic L-amino Acid Decarboxylase Activity: Implications for L-DOPA Treatment in Parkinson's Disease

Maria Hadjiconstantinou et al.

CNS NEUROSCIENCE & THERAPEUTICS (2008)

Article Clinical Neurology

Selective 5HT(2A) and 5HT(6) receptor antagonists promote sleep in rats

Stephen R. Morairty et al.

Article Psychiatry

Better pharmacotherapy for schizophrenia: What does the future hold?

Michael A. Webber et al.

Current Psychiatry Reports (2008)

Article Pharmacology & Pharmacy

Trace amine-associated receptor 1 modulates dopaminergic activity

Lothar Lindemann et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Review Neurosciences

The evolution of drug development in schizophrenia: Past issues and future opportunities

William T. Carpenter et al.

NEUROPSYCHOPHARMACOLOGY (2008)

Article Immunology

Expression of neuronal trace arnine-associated receptor (Taar) mRNAs in leukocytes

Daniel A. Nelson et al.

JOURNAL OF NEUROIMMUNOLOGY (2007)

Review Pharmacology & Pharmacy

Trace amine-associated receptor 1 - Family archetype or iconoclast?

David K. Grandy

PHARMACOLOGY & THERAPEUTICS (2007)

Article Behavioral Sciences

The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia

T. D. Wolinsky et al.

GENES BRAIN AND BEHAVIOR (2007)

Article Pharmacology & Pharmacy

The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases

M. D. Berry

REVIEWS ON RECENT CLINICAL TRIALS (2007)

Review Neurosciences

The mysterious trace amines: Protean neuromodulators of synaptic transmission in mammalian brain

Scott A. Burchett et al.

PROGRESS IN NEUROBIOLOGY (2006)

Article Psychiatry

The NIMH-MATRICS consensus statement on negative symptoms

B Kirkpatrick et al.

SCHIZOPHRENIA BULLETIN (2006)

Review Pharmacology & Pharmacy

A renaissance in trace amines inspired by a novel GPCR family

L Lindemann et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2005)

Article Neurosciences

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

JS Rodefer et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2005)

Review Pharmacology & Pharmacy

Drug induced weight gain, an impediment to successful pharmacotherapy:: Focus on antipsychotics

T Baptista et al.

CURRENT DRUG TARGETS (2004)

Article Endocrinology & Metabolism

Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry

B Künnecke et al.

OBESITY RESEARCH (2004)

Review Clinical Neurology

Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia

A Abi-Dargham et al.

NEUROSCIENTIST (2003)

Article Health Policy & Services

The impact of weight gain on quality of life among persons with schizophrenia

DB Allison et al.

PSYCHIATRIC SERVICES (2003)

Review Neurosciences

Genetic animal models: focus on schizophrenia

RR Gainetdinov et al.

TRENDS IN NEUROSCIENCES (2001)

Article Multidisciplinary Sciences

Trace amines: Identification of a family of mammalian G protein-coupled receptors

B Borowsky et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Review Pharmacology & Pharmacy

Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence

A Carlsson et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)